Epion Therapeutics is conducting Phase 3 clinical trials for an investigational treatment called EpiSmart™. This minimally invasive procedure involves applying…
Originally published in NKCf Update (June 2024). Twelve years ago, an Australian optometrist posed an alarming observation. 'Where,' he asked, 'were the…
Originally published in NKCF Update (June 2024). Medical device businesses, pharmaceutical companies, the National Eye Institute, university medical centers, and…